INTERNATIONAL PATENT: KYVERNA THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS FOR TREATING MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES USING ANTI-CD19 CAR-T CELL THERAPIES"

GENEVA, May 15 -- KYVERNA THERAPEUTICS, INC. (5980 Horton St, STE 550Emeryville, California 94608) filed a patent application (PCT/US2024/053943) for "METHODS FOR TREATING MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES USING ANTI-CD19 CAR-T CELL THERAPIES" on Oct 31, 2024. With publication no. WO/2025/096818, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHUNG, James (c/o Kyverna Therapeutics, Inc.5980 Horton St, STE 550Emeryville, California 94608), VAN BLARCOM, Tom (c/o Kyverna Therapeutics, Inc.5980 Horton St, STE ...